Immune Checkpoint Drugs in Oncology: Analytical Tool – A Must-Have Handbook for Business Developers, BI/CI Operatives, and Clinical Developers
April 25, 2024 10:26 ET
|
Research and Markets
Dublin, April 25, 2024 (GLOBE NEWSWIRE) -- The "Immune-checkpoint Drugs in Oncology: Analytical Tool" report has been added to ResearchAndMarkets.com's offering.Cancer cells sometimes find ways to...
PD-1 and PD-L1 Inhibitors Competitive Landscape Report 2024: Clinical Assessment of Over 200 Drugs Being Developed by More than 180 Companies
March 01, 2024 08:58 ET
|
Research and Markets
Dublin, March 01, 2024 (GLOBE NEWSWIRE) -- The "PD-1 and PD-L1 Inhibitors - Competitive Landscape, 2024" report has been added to ResearchAndMarkets.com's offering.This "PD-1 and PD-L1 Inhibitors -...
Global Next Generation Immunotherapies Market Forecast Report to 2028, by Drug Class, Route of Administration, Distribution Channel and Geography
February 01, 2024 10:27 ET
|
Research and Markets
Dublin, Feb. 01, 2024 (GLOBE NEWSWIRE) -- The "Global Next Generation Immunotherapies Market (2023-2028) by Drug Class, Route of Administration, Distribution Channel, and Geography, Competitive...
Immuno-Oncology Market Poised for Substantial Growth, Driven by Advanced Technologies and Biomarker Integration
January 31, 2024 08:10 ET
|
Research and Markets
Dublin, Jan. 31, 2024 (GLOBE NEWSWIRE) -- The "Immuno-Oncology Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application,...
Metastatic Cancer Drugs Market Size Set to Expand Globally
January 18, 2024 21:23 ET
|
Research and Markets
Dublin, Jan. 18, 2024 (GLOBE NEWSWIRE) -- The "Metastatic Cancer Drugs Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. The metastatic cancer drugs market is...
Global Cancer Therapeutics Market (2023-2028): Cancer Chemotherapy Dominates Market - A Closer Look at Therapeutic Types
September 07, 2023 05:58 ET
|
Research and Markets
Dublin, Sept. 07, 2023 (GLOBE NEWSWIRE) -- The "Global Cancer Therapeutics Market (2023-2028) by Therapeutic Type, Drug Type, Application, End-User and Geography, Competitive Analysis, Impact of...
TIGIT Inhibitors Revolutionize Immune System Control: A Comprehensive Analysis of Clinical Trials and Market Dynamics
September 06, 2023 10:34 ET
|
Research and Markets
Dublin, Sept. 06, 2023 (GLOBE NEWSWIRE) -- The "Anti TIGIT Antibody Market Opportunity and Clinical Trials Insight 2024" report has been added to ResearchAndMarkets.com's offering. The report...
Global Checkpoint Inhibitors Competitive Landscape Report 2023: Comprehensive Insights About 180+ Companies and 250+ Drug Profiles
May 08, 2023 06:48 ET
|
Research and Markets
Dublin, May 08, 2023 (GLOBE NEWSWIRE) -- The "Checkpoint Inhibitors - Competitive landscape, 2023" report has been added to ResearchAndMarkets.com's offering.This "Checkpoint inhibitors -...
Global Checkpoint Inhibitors Market Report 2023: Rising Number of Cancer Cases Drives Growth
April 24, 2023 13:18 ET
|
Research and Markets
Dublin, April 24, 2023 (GLOBE NEWSWIRE) -- The "Checkpoint Inhibitors Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. This report provides strategists,...
Trobix Bio Raises $3 Million from Chartered Group to Advance Precision Microbiome Oncology Therapeutics
March 30, 2023 03:00 ET
|
Trobix Bio
Netanya, Israel, March 30, 2023 - Trobix Bio, a company utilizing CRISPR, phage, and synthetic biology technologies to develop advanced precision microbiome oncology therapeutics, announced today the...